Technology | May 07, 2009

University of Illinois Medical Center in Chicago First Hospital to Install Innovative Shape-HF Cardiopulmonary Testing System

Shape-HF objectively measures cardiopulmonary gas exchange easily and quickly without undue strain on the patient.

May 7, 2009 - The University of Illinois Medical Center, the primary teaching facility for the UIC College of Medicine, is the first such institution to install and the innovative Shape-HF Cardiopulmonary Testing System.

Developed by Shape Medical Systems Inc., this noninvasive medical device assesses heart-lung interaction and ventilation in patients with chronic heart failure and other cardiopulmonary disease. While gas exchange testing devices have been used for several years to measure cardiopulmonary response to exercise, Shape-HF is reportedly the first device specifically designed for cardiology. The maker said the Shape-HF is FDA-approved, easy to use, easy on the patient, and provides clinically relevant data that is easy to understand, reproducible and immediately useful to a cardiologist.

Upon being introduced to the Shape-HF System, Abraham Kocheril, M.D., professor of medicine and director of clinical electrophysiology at the University of Illinois at Chicago, saw immediate applications for the device. "It broadens the pool of heart failure patients we are able to accurately test because it is less cumbersome than existing cardiopulmonary testing devices and it is patient friendly for those with heart failure," Dr. Kocheril said.

Shape-HF uses low-intensity, sub-maximal or steady state testing protocols to allow testing of even high-risk patients with little or no discomfort.

The company said measuring patient gas exchange is the best method of assessing patient functional capacity, monitoring their response to therapy and predicting outcome. Shape-HF is designed to quantify the severity of dyspnea on exertion and fatigue and evaluate the interaction between the heart, lungs, and other organ systems. This makes it possible for the physician to evaluate therapy options for the individual patient and track patient progress. In addition, cardiac resynchronization therapy (CRT) has become a mainstay in treating patients with severe heart failure when alternative treatment options have been exhausted.

"The CRT response rate in heart failure patients is about 70 percent,” said Dr. Koucheril. “The Shape-HF System is likely to help us get the remaining 30 percent feeling better – those we call nonresponders – because it lets us objectively measure response to CRT and optimize timing between the atrium and the two ventricles of the heart in real time while the patient is exercising."

The company says this is the first device that objectively measures cardiopulmonary gas exchange easily and quickly without undue strain on the patient and in the office setting. Shape-HF provides real-time physiological assessment to enable CRT optimization during exercise and is cost-effective and easy to use.

For more information: www.shapemedsystems.com

Related Content

Lexington Biosciences Concludes Initial HeartSentry Clinical Study
News | Patient Monitors | August 16, 2018
Lexington Biosciences Inc. recently announced the completion of the initial HeartSentry study conducted at San...
Itamar Medical Launches SleePath for AFib Patients at Heart Rhythm 2018
Technology | Patient Monitors | May 16, 2018
Itamar Medical Ltd. announced the launch of SleePath, the first integrated e-health sleep apnea care pathway monitoring...
News | Patient Monitors | March 09, 2018
Philips recently announced the integration of its IntelliVue Guardian with automated Early Warning Scoring (EWS) into...
Acarix, CADScor System, coronary artery disease detection, clinical study, ACC.17
News | Patient Monitors | March 30, 2017
Acarix AB recently announced the results from a new multi-center trial of its handheld CADScor System for non-invasive...
Corsens Medical, Corsens Cardiac Monitor, FDA 510(k) clearance
Technology | Patient Monitors | December 08, 2016
Corsens Medical Ltd. announced that it has received clearance for a Pre-Marketing Notification (510(k)) with the U.S....
Corsens Cardiac Monitor, FDA 510k pre-market notification
News | Patient Monitors | May 26, 2016
Corsens Medical Ltd. announced it has successfully completed filing of a Pre-Marketing Notification (510(k)) with the U...
Philips, FDA 510k clearance, Expression MR400, MRI patient monitor
Technology | Patient Monitors | February 11, 2016
Royal Philips announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Expression MR400, a new...
Profusa, integrated biosensors, long-term continuous monitoring
News | Patient Monitors | January 15, 2016
Biointegrated sensors for long-term, continuous tracking of body chemistry may make health and disease monitoring as...
sleep apnea, pulse oximetery, congestive heart failure, CHF, pulse-oximetry, Thomas Jefferson University
News | Patient Monitors | September 09, 2015
Researchers at Thomas Jefferson University showed that a simple questionnaire, evaluation and pulse-oximetry monitoring...
Nonin Medical, NoninConnect Model 3230, Bluetooth Smart, wireless finger pulse oximeter, iOS-compatible, Apple

Image courtesy of Nonin Medical

Technology | Patient Monitors | August 14, 2015
August 14, 2015 — Nonin Medical Inc.
Overlay Init